Table of Contents

1 Etravirine Market Overview

• 1.1 Product Overview and Scope of Etravirine
• 1.2 Classification of Etravirine by Types
  • 1.2.1 Global Etravirine Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Etravirine Revenue Market Share by Types in 2018
  • 1.2.3 25 mg Tablets
  • 1.2.4 100 mg Tablets
  • 1.2.5 200 mg Tablets
• 1.3 Global Etravirine Market by Application
  • 1.3.1 Global Etravirine Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Adults
  • 1.3.3 Pediatric patients
• 1.4 Global Etravirine Market by Regions
  • 1.4.1 Global Etravirine Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Etravirine Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Etravirine Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Etravirine Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Etravirine Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Etravirine Status and Prospect (2014-2024)
• 1.5 Global Market Size of Etravirine (2014-2024)

2 Manufacturers Profiles

• 2.1 Janssen Therapeutics
  • 2.1.1 Business Overview
  • 2.1.2 Etravirine Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Janssen Therapeutics Etravirine Revenue, Gross Margin and Market Share (2017-2018)

3 Global Etravirine Market Competition, by Players

• 3.1 Global Etravirine Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Etravirine Players Market Share
  • 3.2.2 Top 10 Etravirine Players Market Share
• 3.3 Market Competition Trend

4 Global Etravirine Market Size by Regions

• 4.1 Global Etravirine Revenue and Market Share by Regions
• 4.2 North America Etravirine Revenue and Growth Rate (2014-2019)
• 4.3 Europe Etravirine Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Etravirine Revenue and Growth Rate (2014-2019)
• 4.5 South America Etravirine Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Etravirine Revenue and Growth Rate (2014-2019)

5 North America Etravirine Revenue by Countries

• 5.1 North America Etravirine Revenue by Countries (2014-2019)
• 5.2 USA Etravirine Revenue and Growth Rate (2014-2019)
• 5.3 Canada Etravirine Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Etravirine Revenue and Growth Rate (2014-2019)

6 Europe Etravirine Revenue by Countries

• 6.1 Europe Etravirine Revenue by Countries (2014-2019)
• 6.2 Germany Etravirine Revenue and Growth Rate (2014-2019)
• 6.3 UK Etravirine Revenue and Growth Rate (2014-2019)
• 6.4 France Etravirine Revenue and Growth Rate (2014-2019)
• 6.5 Russia Etravirine Revenue and Growth Rate (2014-2019)
• 6.6 Italy Etravirine Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Etravirine Revenue by Countries

• 7.1 Asia-Pacific Etravirine Revenue by Countries (2014-2019)
• 7.2 China Etravirine Revenue and Growth Rate (2014-2019)
• 7.3 Japan Etravirine Revenue and Growth Rate (2014-2019)
• 7.4 Korea Etravirine Revenue and Growth Rate (2014-2019)
• 7.5 India Etravirine Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Etravirine Revenue and Growth Rate (2014-2019)

8 South America Etravirine Revenue by Countries

• 8.1 South America Etravirine Revenue by Countries (2014-2019)
• 8.2 Brazil Etravirine Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Etravirine Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Etravirine Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Etravirine by Countries

• 9.1 Middle East and Africa Etravirine Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Etravirine Revenue and Growth Rate (2014-2019)
• 9.3 UAE Etravirine Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Etravirine Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Etravirine Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Etravirine Revenue and Growth Rate (2014-2019)

10 Global Etravirine Market Segment by Type

• 10.1 Global Etravirine Revenue and Market Share by Type (2014-2019)
• 10.2 Global Etravirine Market Forecast by Type (2019-2024)
• 10.3 25 mg Tablets Revenue Growth Rate (2014-2024)
• 10.4 100 mg Tablets Revenue Growth Rate (2014-2024)
• 10.5 200 mg Tablets Revenue Growth Rate (2014-2024)

11 Global Etravirine Market Segment by Application

• 11.1 Global Etravirine Revenue Market Share by Application (2014-2019)
• 11.2 Etravirine Market Forecast by Application (2019-2024)
• 11.3 Adults Revenue Growth (2014-2019)
• 11.4 Pediatric patients Revenue Growth (2014-2019)

12 Global Etravirine Market Size Forecast (2019-2024)

• 12.1 Global Etravirine Market Size Forecast (2019-2024)
• 12.2 Global Etravirine Market Forecast by Regions (2019-2024)
• 12.3 North America Etravirine Revenue Market Forecast (2019-2024)
• 12.4 Europe Etravirine Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Etravirine Revenue Market Forecast (2019-2024)
• 12.6 South America Etravirine Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Etravirine Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine.

Scope of the Report:
The global Etravirine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Etravirine.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Etravirine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Etravirine market by product type and applications/end industries.

Market Segment by Companies, this report covers
Janssen Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
25 mg Tablets
100 mg Tablets
200 mg Tablets

Market Segment by Applications, can be divided into
Adults
Pediatric patients